发明名称 |
PYRAZOLYL 5-THIOGLYCOSIDE COMPOUND |
摘要 |
PROBLEM TO BE SOLVED: To provide a new pyrazolyl 5-thio-β-D-glycoside compound controlling IGT (impaired glucose tolerance) by inhibiting an SGLT1 activity selectively to suppress the glucose absorption from digestive tract. SOLUTION: This pyrazolyl 5-thioglycoside compound expressed by formula (I) [wherein, Z is a 1-6C alkyl; R<SP>1</SP>to R<SP>3</SP>are each the same or different H or a 1-6C alkyl; (n) is an integer of 1 to 4; and X is hydroxy, -O(1-4C alkylphenyl) or the like], its pharmaceutically acceptable salt or their hydrates are provided. COPYRIGHT: (C)2009,JPO&INPIT
|
申请公布号 |
JP2009167103(A) |
申请公布日期 |
2009.07.30 |
申请号 |
JP20060128679 |
申请日期 |
2006.05.02 |
申请人 |
TAISHO PHARMACEUTICAL CO LTD |
发明人 |
KAKINUMA HIROYUKI;KOBASHI YOHEI |
分类号 |
C07H17/02;A61K31/7056;A61P3/10;A61P43/00 |
主分类号 |
C07H17/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|